EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence and Factors Associated With Symptom Profiles of Disorders of Gut‐Brain Interaction in Obesity Before and After Treatment

Esther Colomier, Janita Halminen, Malin Björck, Gudrún Höskuldsdóttir, Karin Mossberg, My Engström, Björn Eliasson, Ville Wallenius, Lars Fändriks iD, Jan Tack, Hans Törnblom iD, Magnus Simrén

Neurogastroenterology & Motility · 2025

DOI: 10.1111/nmo.70017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurogastroenterology & Motility, 2025. Verfasst von Esther Colomier und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Obesity, Gastrointestinal Diseases, Brain-Gut Axis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Göteborgs Universitet, Novo Nordisk Fonden, Västra Götalandsregionen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Disorders of gut‐brain interaction (DGBI) in obesity could impair health outcomes. Therefore, we aimed to study the prevalence and burden of symptoms compatible with a DGBI in obesity and assess the effect of obesity treatment on comorbid DGBI.

Methods

We used baseline and two‐year follow‐up data from a prospective non‐randomized cohort study including patients with obesity referred for obesity treatment. Patients completed the Rome III questionnaire before and after receiving Roux‐en‐Y gastric bypass (RYGB), sleeve gastrectomy (SG), or medical treatment. Validated questionnaires and blood parameters were used to assess the burden of DGBI in obesity.

Results

In total, 939 patients (73% female, 44 ± 13 years, 42 ± 5 kg/m 2 , 36% medical treatment, 38% RYGB, 20% SG) completed the Rome III questionnaire at baseline and 651 patients (32 ± 6 kg/m 2 ) at follow‐up. The proportion of patients with a DGBI symptom profile was reduced from 61% (24% esophageal, 27% gastroduodenal, 38% bowel, and 8% anorectal disorders) to 53% (15% esophageal, 25% gastroduodenal, 34% bowel, 8% anorectal disorders) at follow‐up. There was a substantial shift between the baseline and follow‐up DGBI symptom profiles across all GI regions. Patients with a DGBI symptom profile at baseline presented with more severe psychological distress, a poorer quality of life, and were more likely to be female.

Conclusions

DGBI symptom profiles are common and can impair health outcomes in obesity. Obesity treatment lowers the prevalence of DGBI symptoms in general, but an important shift between baseline and follow‐up DGBI symptom profiles across all GI regions can be observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityGastrointestinal DiseasesBrain-Gut AxisHumansFemaleAdultMaleMiddle AgedPrevalenceProspective StudiesGastric BypassFollow-Up StudiesCohort StudiesSurveys and Questionnaires

Stichwörter der Autor:innen

disorders of gut‐brain interactionfunctional dyspepsiairritable bowel syndromeobesityprevalence

Autor:innen und Institutionen

  • Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium.
  • Department of Medicine, Sahlgrenska University Hospital Gothenburg, Gothenburg, Sweden.
  • Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Region Västra Götaland, Sahlgrenska University Hospital, Department of Surgery, Gothenburg, Sweden.

ORCID-Profile: Lars Fändriks, Hans Törnblom

Förderung

  • Göteborgs Universitet
  • Novo Nordisk Fonden
  • Västra Götalandsregionen

Zitieren

APA

Colomier, E., Halminen, J., Björck, M., Höskuldsdóttir, G., Mossberg, K., Engström, M., Eliasson, B., Wallenius, V., Fändriks, L., Tack, J., Törnblom, H., & Simrén, M. (2025). Prevalence and Factors Associated With Symptom Profiles of Disorders of Gut‐Brain Interaction in Obesity Before and After Treatment. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.70017

Vancouver

Colomier E, Halminen J, Björck M, Höskuldsdóttir G, Mossberg K, Engström M, et al. Prevalence and Factors Associated With Symptom Profiles of Disorders of Gut‐Brain Interaction in Obesity Before and After Treatment. Neurogastroenterology & Motility. 2025. doi:10.1111/nmo.70017

BibTeX
@article{Colomier2025,
  author = {Colomier, Esther and Halminen, Janita and Björck, Malin and Höskuldsdóttir, Gudrún and Mossberg, Karin and Engström, My and Eliasson, Björn and Wallenius, Ville and Fändriks, Lars and Tack, Jan and Törnblom, Hans and Simrén, Magnus},
  title = {Prevalence and Factors Associated With Symptom Profiles of Disorders of Gut‐Brain Interaction in Obesity Before and After Treatment},
  journal = {Neurogastroenterology & Motility},
  year = {2025},
  doi = {10.1111/nmo.70017}
}
Kostenlos starten →